About Retinal Drugs
Retinal drugs are the medications that are used for the treatment of retinal diseases.
Technavio’s analysts forecast the global retinal drugs market to grow at a CAGR of 7.63% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global retinal drugs market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Retinal Drugs Market 2018-2022
Technavio recognizes the following companies as the key players in the global retinal drugs market: ALLERGAN, Bayer, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, and Valeant Pharmaceuticals.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is development of innovative therapies. Researchers are focusing on the development of advanced technologies such as gene therapy, eye drops, radiation, and stem cells for the treatment of retinal diseases. Additionally, companies are also focusing on developing combination therapies for the treatment of retinal diseases.”
According to the report, one driver in the market is rise in the prevalence of retinal diseases. It has been observed that the prevalence of retinal diseases such as RVO, mCNV, diabetic retinopathy, wet AMD, and DME is high in both the developing and developed countries. One of the leading causes of visual disability in the industrialized countries is AMD.
Further, the report states that one challenge in the market is high cost associated with retinal disease therapy. The high cost of retinal drugs is limiting their widespread adoption, and in turn, inhibiting their market growth. EYLEA costs approximately $1,850 per intravitreal dose, LUCENTIS 0.5 mg costs approximately $2,000 per dose, and conbercept costs approximately $1,150 per dose.
ALLERGAN, Bayer, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, and Valeant Pharmaceuticals.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook